
Loading, please wait...

Loading, please wait...

A head-to-head meta-analysis compared Xpert MTB/RIF with the newer Xpert MTB/RIF Ultra assay for tuberculosis diagnosis. Across the included studies, Ultra showed higher pooled sensitivity than the earlier Xpert platform, while specificity was slightly lower. The improvement in sensitivity was particularly relevant in paucibacillary presentations, including forms of disease in which bacterial burden can be low. For practicing pulmonologists, this matters because a highly sensitive rapid molecular test can improve diagnostic confidence when smear microscopy is negative but the clinical suspicion of TB remains substantial. The trade-off is that a modest reduction in specificity means results must still be interpreted in the context of symptoms, imaging and epidemiologic risk. This publication fits strongly with NAPCON's focus on molecular diagnostics and TB programmatic care. It also illustrates why newer molecular platforms should be understood as part of a diagnostic algorithm rather than treated as isolated yes/no tests. The evidence supports using Ultra to improve detection in selected settings, while recognizing that specimen type and disease site continue to influence test performance and that culture and other investigations may still be required.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A head-to-head meta-analysis compared Xpert MTB/RIF with the newer Xpert MTB/RIF Ultra assay for tuberculosis diagnosis. Across the included studies, Ultra showed higher pooled sensitivity than the earlier Xpert platform, while specificity was slightly lower. The improvement in sensitivity was particularly relevant in paucibacillary presentations, including forms of disease in which bacterial burden can be low. For practicing pulmonologists, this matters because a highly sensitive rapid molecular test can improve diagnostic confidence when smear microscopy is negative but the clinical suspicion of TB remains substantial. The trade-off is that a modest reduction in specificity means results must still be interpreted in the context of symptoms, imaging and epidemiologic risk. This publication fits strongly with NAPCON's focus on molecular diagnostics and TB programmatic care. It also illustrates why newer molecular platforms should be understood as part of a diagnostic algorithm rather than treated as isolated yes/no tests. The evidence supports using Ultra to improve detection in selected settings, while recognizing that specimen type and disease site continue to influence test performance and that culture and other investigations may still be required.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back